Cambridge Cancer Genomics
AcquiredCCG.ai empowers clinicians to make personalised treatment strategies…
Cambridge, United Kingdom · Founded 2015 · $4.5M raised
- Total Funding
- $4.5M
- Last Round
- $4.5M Series ADec 2018
- Rounds
- 1
- Acquisition Date
- Jun 2021
About
CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to info@ccg.ai
Summary
Cambridge Cancer Genomics is a Genomics company based in Cambridge, United Kingdom, founded in 2015. It has raised $4.5M in total across 1 round, most recently a $4.5M Series A round in Dec 2018. Investors include Refactor Capital, Romulus Capital and AME Cloud Ventures.
Funding History
Jun 2021
Sign up to see all 2 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ccgenomics"><img src="https://indexed.vc/api/badge/company/ccgenomics" alt="Cambridge Cancer Genomics on Indexed.vc" width="260" height="76" /></a>
.png)